4FOX Ventures
Switzerland
- Lausanne
- 17/11/2022
- Series A
- $5,000,000
4FOX Ventures is a leading Swiss healthcare and technology focused venture capital team managing a portfolio of over 10 highly innovative and fast-growing companies composed, amongst others, of:
(i) Ecorobotix (https://www.ecorobotix.com/en/);
(ii) Neomedical (https://neo-medical.com/);
(iii) Giotto Compliance (https://giotto.ai/);
(iv) Aspivix (https://www.aspivix.com/);
(v) Artiria Medical (https://artiria-medical.com/);
(vi) Positrigo (https://www.positrigo.com/);
(vii) Vima (https://vima-swiss.com/);
(viii) Faveeo (https://www.faveeo.com/);
(ix) Kairos (https://www.kairosfire.com/);
(x) Scailyte (https://scailyte.com/).
We usually invest as first institutional investor in early stage Swiss companies with potential to develop and tackle early on the booming Asian market.
Through active board representation, we deliver direct operational and industry support.
- Industry Venture Capital and Private Equity Principals
- Website http://4fox-ventures.com/
- LinkedIn https://www.linkedin.com/company/4fox-ventures/
Amphix Bio | $12,500,000 | (Dec 19, 2025)
arcads AI | $16,000,000 | (Dec 19, 2025)
Katalist | $1,500,000 | (Dec 19, 2025)
Syremis Therapeutics | $165,000,000 | (Dec 19, 2025)
Gravity Labs Co., Ltd. | $17,000,000 | (Dec 19, 2025)
Edison Scientific | $70,000,000 | (Dec 19, 2025)
InfiniteWatch | $4,000,000 | (Dec 19, 2025)
Thread | $18,000,000 | (Dec 19, 2025)
Neural Concept | $100,000,000 | (Dec 19, 2025)
SkillCorner | $60,000,000 | (Dec 19, 2025)
Wearlinq | $14,000,000 | (Dec 18, 2025)
T-CURX GmbH | $20,000,000 | (Dec 18, 2025)